NL-OMON31574撤回不适用
The Nanoduct study: a new sweat test system tested - The Nanoduct study
RIVM0 个研究点目标入组 330 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Newborns referred to the hospital for a sweat test after newborn screening. Children aged < 2 months with a suspected diagnosis of Cystic Fibrosis. informed consent has been obtained from the parents.
排除标准
- •Newborns with severe eczema or sepsis (sweat test results are not reliable). Infants with meconiumileus. Informed consent cannot be obtained.
研究者
相似试验
招募中
不适用
Clinical evaluation of a new sweat test system in the diagnosis of cystic fibrosis after newborn screening1001567410010613Cystic FibrosisNL-OMON32874Atrium Medisch Centrum100
尚未招募
2 期
A study to test the benefits of the Ayurvedic Proprietary Medicine Product on Dental HealthCTRI/2023/02/050139nilever Industries Pvt Ltd
已完成
不适用
A study to test the benefits of the Product on dental problemsCTRI/2022/02/040692nilever Industries Pvt Ltd193
尚未招募
不适用
A study to test the benefits of the Product on Dental HealthCTRI/2023/02/049984nilever Industries Pvt Ltd
已完成
2 期
Study for hair growth and hair fallCTRI/2022/09/045239Monkey Creations Inc MCI54